Utilizing Liquid Biopsy to Diagnose Pancreatic Cancer

Researchers from the Mayo Clinic and other institutions conducted a study to determine the feasibility and efficacy of circulating tumor DNA (ctDNA) profiling for the diagnosis of pancreatic ductal adenocarcinoma (PDAC). CtDNA profiling is a non-invasive liquid biopsy method that measures DNA fragments from cancer cells that have been released into the bloodstream. PDAC is … Continue reading Utilizing Liquid Biopsy to Diagnose Pancreatic Cancer